Work

FGF2 Mediates Resistance In CML Patients In The Absence Of Kinase Domain Mutations, and Resistance Is Overcome By Ponatinib

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.3983.3983

Authors: Elie Traer, Nathalie Javidi-Sharifi, Anupriya Agarwal, Jennifer B Dunlap, Isabel English, Jacqueline Martinez, Jeffrey W. Tyner, Melissa Wong, Brian J. Druker

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute, Howard Hughes Medical Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2513238507

FWCI:

Cites:

Cited by:

Related to: 10